FDA Guidance titled “Further Testing of Donations that are Reactive on a Licensed Donor Screening Test for Antibodies to Hepatitis C Virus; Guidance for Industry” was released on October 2, 2019 and recommends that CTS modify our current HCV reflex testing algorithm to support these best practices. The new algorithm will take effect on April 20, 2020.
Check out the Communication page for the complete details by clicking the link: Communications
In 2016, the Procleix Panther instrument was introduced by Grifols in support of automated NAT ZIKA ...
CTS implement the Bio-Rad Geenius HIV 1/2 supplemental assay on Monday September 21, 2020. The newly...
The CTS 2020 Annual Laboratory Survey is on its way to your email box. We would appreciate you takin...
On April 15, 2019, the New CTS Laboratory Information System has been successfully implemented in Po...
Creative Testing Solutions, the largest nonprofit blood testing organization in the U.S., today anno...
As a service to our partners, CTS provides a copy of all licenses and accreditations on our website....